chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling in arms followed immediately by paralysis in arms in a matter of minutes by the time EMT's arrived completely paralyzed neck down.  ICU 2 weeks Rehab hospital 5 weeks  Nursing home with rehabilitation providers currently.  Lesions were on spinal cord.  Dr. (neurologist and medical school professor) told her daughter it was due to the flu vaccine she had five weeks prior. She received iv steroids to help heal lesions.
This spontaneous report was received from a approximately 40 years old female patient (pharmacist) reporting on herself. In approximately August 2004 (also reported as 5 or 10 years ago) the patient was vaccinated with at least 5 doses of (Oka/Merck) VARIVAX (dose, lot # and route of administration were not reported). It was reported that the patient never seroconverted. The outcome of the event was not recovered/resolved. This is one of several reports received from the same reporter. Additional information has been requested.
Local erythematous swelling. 8cm wide, 9cm long to right upper arm.  Warm to touch, tender.
Severe local reaction 40mm X 25mm induration with erythema swollen tender anterior auxillary nodes - celluitis.
shingles; Information has been received from a lawyer regarding a case in litigation concerning to a female patient of an unknown age. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.   In 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, anatomical application, lot number and expiration date were not reported) for the long-term prevention of shingles and or zoster-related conditions.   On an unknown date, subsequent to the patient's zoster vaccine live (ZOSTAVAX) inoculation, the patient experienced shingles, and she was treated by a physician. The patient had and would continue suffer ongoing injuries; significant medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications and supplies.   The causal relationship between shingles and zoster vaccine live (ZOSTAVAX) was related.
8.21.2021  for cough, nasal and chest congestion since midnight. patient reports feeling worst this AM. she is fully vaccinated. She was recently exposed and now having syptoms
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date in 2007 the patient was vaccinated with the first dose of GARDASIL (route, dose and lot # were unknown) the second dose of GARDASIL (route, dose and lot # were unknown) on an unknown date in 2010. The patient was in the office today, 25-JUL-2013, was attempting to get the third dose of GARDASIL. No adverse reaction reported. Additional information has been requested.
Four days after I had the shot, I became severely sick which had me bed ridden for two and a half weeks.
Employee stated two hours after receiving HBV booster, she started itching, developed a rash on arms. Reported same to employee health nurse on 8/23/04. No other complaints. Booster given because employee titer was negative after series of 3.
Myalgia, Arthralgia, Fever, chills, pain at injection site, fatigue Narrative:
Patient got vaccinated by the pharmacist at 09:57 am and while waiting for 15 minutes at around 10:05am patient felt dizzy  and patient told family member that she felt dizzy and having bad test. patient also told family member she have hard time of hearing what the family member was saying to the patient. family member ask pharmacist for help and pharmacist called 911 and provided patient water. After 5 minutes EMT personal showed up onsite and took over the incident.
Started  on 10/11/2022, the patient had swollen lymph nodes under and in front of the right ear with a rash inside the ear and across the cheekbone. Over the next several days, the lymph nodes continued to swell, the rash became red with papule like structures on the face and in the ear with a yellow/white center. Under the right eye swelled and became red as well. Most of the swelling has since decreased except the lymph node under the right ear. The papule like structures have become raised dark scabs (one in ear and two on the cheekbone- one was quite large the other medium size) at time of interview on October 26th at 2 pm.
allergic reaction to the vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of allergy to vaccine in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included shingles vaccine with an associated reaction of no adverse event (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced allergy to vaccine. On an unknown date, the outcome of the allergy to vaccine was recovered/resolved.   It was unknown if the reporter considered the allergy to vaccine to be related to Shingles vaccine.     Additional Information: GSK receipt date: 26-JUL-2022 Reporter's comments: This case was reported by a consumer via interactive digital media. Patient self-reported the case. Patient had the shingles once and that was enough to motivate patient to get the vaccine.  After the second shot patient had an allergic reaction to the vaccine.  Patient pulled through that ordeal and it was proved that not everyone had the same biochemistry or outcome with vaccines.
Moderna Covid-19 Vaccine EUA Slight soreness at injection site  and mild fatigue for a few days
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a nurse regarding a female patient who on 3/3/2004 at 14 months, received a fourth dose of Prevnar. on 3/8/2006, at 3 years of age, the child developed respiratory syncytial virus and sinusitis. On 3/13/2006, the patient developed overwhelming streptococcus pneumoniae sepsis and subsequently died. No know allergies, no previous drug reactions. Indication for Prevnar was immunization. Product was administered on 3/3/2004. Dose regimen was 0.5ml 1 time per day intramuscular. Concomitant medications were not reported. On 3/3/2004, the patient received a fourth dose of Prevnar. On 3/8/2006, the patient developed respiratory syncytial virus (respiratory syncytial virus infection) and sinusitis. Treatment included breathing treatments. On 3/13/2006, the child was vomiting and the patients conditions worsened. The child was evaluated at the doctors office and a blood culture revealed streptococcus pneumoniae. No serotype testing was performed. On the same day, the patient was hospitalized for pneumoniae sepsis (pneumococcal sepsis) (drug ineffective). The pneumococcal sepsis resulted in multi system organ failure and the patient subsequently died on the same day. The cause of death was reported as overwhelming streptococcus pneumoniae sepsis resulting in multi system organ failure. Blood culture (results streptococcus pneumoniae) was done on 3/13/2006. No additional information was available at the time of this report. 6/19/06 Received hospital medical records which revealed patient experienced overwhelming septic shock from streptococcus pneumoniae causing multisystem organ failure.  Hospitalized & expired on 3/13/06.   DC summary indicates patient had URI for several days which had gotten progressively worse.  6/19/06 Received medical records from hospital which reveal transferred in on 3/13/06 with a diagnosis of overwhelming septic shock from streptococcus pneumoniae causing multisystem organ failure.  Patient had progressively worsening respiratory infection w/dry nonproductive cough for approx 10 days prior to admit.  Patient expired 3/13/06 after coding x 2.  A CXR showed left pleural effusion vs empyema w/near whiteout of left lung field.  Aspiration of the left pleural space revealed approx 30 ml of purulent dark colored fluid.  C/S of the pleural fluid revealed strep pneumoniae heavy growth.  She was unable to be resuscitated after the second code.  1/25/08 Reviewed death certificate which states COD as multiorgan system failure with septic shock, streptococcal pneumoniae empyema & sepsis & recent RSV infection as contributing causes.
Twenty-four to forty-eight hours after vaccination, muscle aches all over and feeling exhausted for three weeks, I felt yucky. I tried getting an appointment with my doctor but had no luck, I also started feeling pain in my mouth and my teeth. This is the real health even ever. I had never had a cavity in my life and after vaccine this started happening. This shot affected me because now my hair is falling out and I've always been healthy.
Left-arm twitching for 3 days. Full body rash, fever, lasted 12 hours. Diarrhea and stomach cramping for 4 hours.  Joint pain in hands and fingers, chest pains, and headache lasted until now, date of 10/4/21.   Fatigue and irritability lasting until now, date of 10/4/21.
GUILLAIN BARRE SYNDROME; This spontaneous report received from a patient concerned a 43-year-old male of unspecified race. The patient's weight was 147 pounds, and height was 67 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808982 expiry: unknown) dose was not reported, 01 total, administered on 09-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. In APR-2021, 3 weeks post vaccination, the patient started experiencing symptoms like muscle pain all over the body, his feet felt like he had walked for miles, the bottom of his feet and fingers felt numb, he felt tingling and numbness that was getting worse, his legs started to feel numb; and arms and hands also started to feel the same. He tried to remember what he ate and what he did and may be what was causing the symptoms, he was finding it hard to do his job. On 23-JUL-2021, the patient visited the emergency room and was diagnosed with Guillain Barre syndrome was hospitalized for 5 days and discharged on 28-Jul-2021. Patient was administered unspecified treatment medication and did not remember what it was. The patient's symptoms were not resolved and he also reported that he felt worse when he laid down and was unable to sleep. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from guillain barre syndrome.  This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210943950-COVID-19 VACCINE AD26.COV2.S- Guillain barre syndrome. This event is labeled per RSI and is therefore considered potentially related.
CONTINUE BENADRYL AND CLARITIN START ANTIBIOTIC FOR POSSIBLE CELLULITIS
Patient reports her throat was starting to close and was feeling dizzy after 15-20 minutes of receiving vaccine. Cleared by EMS
Sore arm began around 5pm on date of injection. 11:50 pm after a hot shower I began to experience shivering. I had an ice pack on the injection site for swelling and pain. After removing the ice pack I had convulsive shivering and low body temp for two and a half hours. Also noticed while laying on right side of body I had very sharp pain in my chest, right side, central location. Worse when inhaling.  Layered up on clothing, blankets, attempted to fall asleep. Woke up in the morning sweating with a fever of 100.6 and extreme body pain and a migraine. Had no energy, no appetite, and a lot of pain.  Arm pain was slightly better than it had been at night but still significant.  Took 800mg ibuprofen to alleviate the symptoms. Slept until 1:30pm. Went to work in tears, left work early. Will not be attending work tomorrow 11/24 due to symptoms. Migraine still active, body pain 7/10, arm pain 5/10. Fever seems to have ended
elevated heart rate; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 Immunization. The following information was reported: HEART RATE INCREASED (non-serious), outcome "unknown", described as "elevated heart rate". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reported that her husband had stated that he had had an elevated heart rate since receiving the Covid-19 booster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After 5 minutes of receiving her shot client stated "her stomach was hurting". I asked her if she needed to go to the bathroom and she said yes. I accompanied her to the restroom and she said she got really dizzy and lightheaded. I had her lower her head onto her knees, got her a wet towel from the sink. After the episode passed I accompanied her along with her mother to the exam room where she laid down. I elevated her feet and placed another cloth on her head and neck. Her B/P at that time was 87/56. Approx. 5 minutes later her B\P remained the same. At 9:10a she felt well enough to sit up on the table. I retook her B/P and it was 101/80. She had some fresh water and was ready to leave. I accompanied her to the waiting room with her mom and sister where they were getting a release for school. I called the clients mom at 10A and mom said she was fine, watching TV on the couch.
Swelling & redness at injection site, fever, screaming & crying for 3 or more hours. Administered baby Tylenol, cold compress at injection site.
Right arm swelling, itchiness a few hours after 2nd dose of Moderna.  Pt reported on 10/30 when presented for booster.
Information has been received from a certified medical assistant concerning a 37 month old white female with no medical history and no allergies who on 13-Nov-2001 was vaccinated subcutaneously in the left arm with a first dose of varicella virus vaccine live (lot #639128/0567L). On 13-Nov-2001 the patient was also vaccinated subcutaneously in the right arm with a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (lot #639570/0698L). There was no illness at the time of vaccination. On 22-Dec-2003 the patient developed a moderate case of the chicken pox. Unspecified medical attention was sought and no treatment was required. Subsequently, the patient recovered. No product quality complaint was involved. No further information is expected.
PT received 1 dose 5/20/23.  Received another dose 5/26/23
pain at the injection site / pain; This case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site muscle pain. On an unknown date, the outcome of the injection site muscle pain was recovered/resolved.   It was unknown if the reporter considered the injection site muscle pain to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The reporter stated that the patient experienced injection site muscle pain after vaccination. The reporter consented to follow up.
Pt. complains pain in upper right arm since receiving vaccine. Painful to comb hair, etc. Slight throbbing in arm at rest. Has not seen doctor. Went to dr. got steroid pak- 2/24/15.
Pt diagnosed with developmental delay by Developmental Pediatrician on 5/8/2006 as evidenced by lack of verbalization, delayed fine motor skills, and disorganized.  Pt requires individual therapy for speech and motor skills at cost to family. Pt has had a total of 10 vaccinations and will not receive any more. Pt stopped babbling one week after 6 month shots of DTaP and HiB. 4 page office note received for date of service 10/25/2005-medical information documented physical exam within normal limits with a notation of uticaria scattered all over body-HX of GERD treated with Zantac. Summary HSV documented by physician. Mother declined Prevnar and HBV until 'hives' are gone. Documentation of mother's fear of autism connection with Zantac and the family history of older brother diagnosed with Autism. Comment on fax sheet from physician's office "we have no records of an adverse event". Page 3 of 4 documents lot numbers of the vaccines administered on 10/25/2005.
5:30 that evening, foggy, chills, but hot couldn't get warm, full body muscle aches couldn't hardly touch anything everything hurt including my bones had a headache and fully exhausted.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Concurrent condition and medical history were not reported. On 20-JUL-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (Lot # K011967, expiration date 21-FEB-2016) (Strength, dose and route were not reported). Concomitant medications were not reported. No adverse reactions were reported. This is one of several reports from the same source. Additional information has been requested.
Presented complaining of worsening cough and shortness of breath.  Her workup revealed her to have COVID-19 pneumonia.  She was found to be hypoxic with O2 sats 90% on room air and started on supplemental oxygen. COVID-19 Pneumonia with acute hypoxemic respiratory failure. Elevated procalcitonin, treated with IV antibiotics in the hospital and discharged with Cefpodoxime. Completed remdesivir, last dose 2/16/21 Discharge home with dexamethasone to complete the course.
Extremely sore arm, could not lift arm over shoulder, nausea, body aches, chills, dizziness  Applied ice and took Tylenol/Ibuprofen every 4-5 hours for 24 hours
Client who speaks Mandarin Chinese & very little English had her daughter call HD today 9/20/10 to report swelling in (R) deltoid where she received the vaccine & reports her arm feels "tight". Also reports she cannot reach up. States muscle is sore & "uncomfortable". Denies redness. RN instructed to apply cool compress to area & take Ibuprofen.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist at a pharmacy, recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2013, a pharmacist administered the ZOSTAVAX (lot number, dosage and route of administration not provided) to the patient. In 2016, the patient was treated by a physician at a healthcare facility (hospital) for shingles (It was not further specified if this was an inpatient hospitalization in 2016.) The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization (Dates of inpatient hospitalization not reported), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
Severe fatigue within 8 hours, cold, pain in neck and head, unable to work on 10/4/13 - present.  Head sweat, lost 7 pounds in one week.  Unable to function with mind.  Quietness.
C/O slight headache, mild tingling  and numbness to lips and cheeks, denies any other complaint. 16;10 PO offered ,accepted , states tingling and numbness subsiding and headache better. 16:22 Instructed  to notify PCP or EMS if symptoms  worsen; Verbalise understanding.
2MAR93 3Pm pt is running temp of 101 R; medicated w/APAP every 4 hrs; loss of appetite, fussy, DTP inject site hot, red swollen; 5MAR94 pt awakens w/rash from head to waist; no rash seen on limbs or below the waist; taken to ER  allerg reac
Mother reports fever 103.9 within 12 hours of receiving VARICELLA and MMR vaccines.  Fever lasted 72 hours without other clear signs of infection.
c/o intense soreness in arm radiating into neck, then spread throughout body, redness approx 2" diameter x 48hr;swelling x 48-72hr took Ibuprofen-bedrest;
Hives - itchy, a few mm of swelling underneath, small scabs developed in center, faded after about a week. Mostly upper body: both arms, right hand, right side, upper back, upper chest, left shin. No fever, no feeling of sickness, no nausea. Treated about 2 times a day with OTC hydrocortisone for 2 days, which effectively relieved the itch.
Provider had ordered the Fluzone High-Dose vaccine for this patient. I accidentally gave the patient a regular Fluzone Quadrivalent vaccine, instead of the High-Dose. I didn't realize I did this until after I gave the vaccine, and the patient left the clinic. I immediately informed the doctor, my supervisor, and attempted to contact the patient.
At approx. 2:00 PM  after receiving vaccines the patient was walking down the hallway with grandpa and suddenly went down to the floor.  The MA called for my help and I got a wheelchair and we assisted the patient back into the exam room and on to the exam table. Vital signs were being taken when Dr. and RN nurse manager) came to evaluate the patient. Dr. ordered a glucose to be done at that time.  Vitals and glucose were normal, patient was monitered  approx. 15-20 minutes longer and then discharged home with her grandpa.
no additional adverse details provided; administered Recombivax HB the usbcutaneous route versus the recommended intramuscular route; This spontaneous report was received from a nurse, referring to a 2-month-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies, and concomitant therapies were not reported.  On 20-OCT-2020, the patient was vaccinated with hepatitis b vaccine (recombinant) (RECOMBIVAX HB) lot number S030794, expiration date 02-NOV-2021, as prophylaxis (strength, dose, frequency and anatomical vaccination site were not disclosed). It was reported that the vaccine was administered subcutaneously, instead of via intramuscular route as recommended (incorrect route of product administration). There were no additional adverse events reported or further details provided. The outcomes of incorrect route of product administration and no adverse event were unknown.   combinationproductreport: Yes; brandname: RECOMBIVAX HB SYRINGE (DEVICE); commondevicename: Hepatitis B Vaccine (Recombinant); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: S030794; expirationdate: 02-NOV-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability